Ms Center Of Atlanta

Atlanta, Georgia 30327

0 studies enrolling now · 10 studies all time

What they study most

Acute Brainstem/Cerebellar Syndrome, Alzheimer's Disease, Multiple Sclerosis, Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis, Parkinson Disease Psychosis, Relapsing Remitting Multiple Sclerosis, Transverse Myelitis

Studies at this site

• Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS) — Completed
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study — Stopped early
• Oral Cladribine in Early Multiple Sclerosis (MS) — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis — Completed
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis — Completed
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx — Completed
• A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed